213 related articles for article (PubMed ID: 35291381)
1. Plasma cytokines quantification among
Kamoto K; Chiwaya A; Nambala P; Chammudzi P; Senga E; Chisi J; Matovu E; Musaya J
Malawi Med J; 2021 Dec; 33(4):230-235. PubMed ID: 35291381
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome profiles of Trypanosoma brucei rhodesiense in Malawi reveal focus specific gene expression profiles associated with pathology.
Nambala P; Noyes H; Namulondo J; Nyangiri O; Alibu VP; Nerima B; MacLeod A; Matovu E; Musaya J; Mulindwa J;
PLoS Negl Trop Dis; 2024 May; 18(5):e0011516. PubMed ID: 38701067
[TBL] [Abstract][Full Text] [Related]
3. Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense.
MacLean LM; Odiit M; Chisi JE; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2010 Dec; 4(12):e906. PubMed ID: 21151878
[TBL] [Abstract][Full Text] [Related]
4. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
[TBL] [Abstract][Full Text] [Related]
6. Association of APOL1 renal disease risk alleles with Trypanosoma brucei rhodesiense infection outcomes in the northern part of Malawi.
Kamoto K; Noyes H; Nambala P; Senga E; Musaya J; Kumwenda B; Bucheton B; Macleod A; Cooper A; Clucas C; Herz-Fowler C; Matove E; Chiwaya AM; Chisi JE;
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007603. PubMed ID: 31412021
[TBL] [Abstract][Full Text] [Related]
7. Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.
Kato CD; Alibu VP; Nanteza A; Mugasa CM; Matovu E
PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003835. PubMed ID: 26090964
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda.
Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC
Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of trypanosomiasis in Rumphi district, Malawi: a ten year retrospective study.
Madanitsa M; Chisi J; Ngwira B
Malawi Med J; 2009 Mar; 21(1):22-7. PubMed ID: 19780474
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.
Kuepfer I; Hhary EP; Allan M; Edielu A; Burri C; Blum JA
PLoS Negl Trop Dis; 2011 Mar; 5(3):e968. PubMed ID: 21407802
[TBL] [Abstract][Full Text] [Related]
11. Development of a bio-inkjet printed LAMP test kit for detecting human African trypanosomiasis.
Hayashida K; Nambala P; Reet NV; Büscher P; Kawai N; Mutengo MM; Musaya J; Namangala B; Sugimoto C; Yamagishi J
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008753. PubMed ID: 33091922
[TBL] [Abstract][Full Text] [Related]
12. Human African trypanosomiasis in non-endemic countries.
Sudarshi D; Brown M
Clin Med (Lond); 2015 Feb; 15(1):70-3. PubMed ID: 25650203
[TBL] [Abstract][Full Text] [Related]
13. Human African trypanosomiasis and human immunodeficiency virus co-infection in Western Kenya.
Matete GO; Kajejo OA
East Afr Med J; 2005 Jan; 82(1):20-3. PubMed ID: 16122107
[TBL] [Abstract][Full Text] [Related]
14. Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda.
Fèvre EM; Odiit M; Coleman PG; Woolhouse ME; Welburn SC
BMC Public Health; 2008 Mar; 8():96. PubMed ID: 18366755
[TBL] [Abstract][Full Text] [Related]
15. Thyroid dysfunction in African trypanosomiasis: a possible role for inflammatory cytokines.
Reincke M; Allolio B; Petzke F; Heppner C; Mbulamberi D; Vollmer D; Winkelmann W; Chrousos GP
Clin Endocrinol (Oxf); 1993 Oct; 39(4):455-61. PubMed ID: 8287572
[TBL] [Abstract][Full Text] [Related]
16. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response.
MacLean L; Reiber H; Kennedy PG; Sternberg JM
PLoS Negl Trop Dis; 2012; 6(10):e1857. PubMed ID: 23145191
[TBL] [Abstract][Full Text] [Related]
17. Differences in gene expression profiles in early and late stage rhodesiense HAT individuals in Malawi.
Nambala P; Mulindwa J; Noyes H; Alibu VP; Nerima B; Namulondo J; Nyangiri O; Matovu E; MacLeod A; Musaya J;
PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011803. PubMed ID: 38055777
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity and population structure of Trypanosoma brucei in Uganda: implications for the epidemiology of sleeping sickness and Nagana.
Echodu R; Sistrom M; Bateta R; Murilla G; Okedi L; Aksoy S; Enyioha C; Enyaru J; Opiyo E; Gibson W; Caccone A
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003353. PubMed ID: 25695634
[TBL] [Abstract][Full Text] [Related]
19. The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda.
Fèvre EM; Coleman PG; Odiit M; Magona JW; Welburn SC; Woolhouse ME
Lancet; 2001 Aug; 358(9282):625-8. PubMed ID: 11530149
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for T. brucei rhodesiense sleeping sickness within villages in south-east Uganda.
Zoller T; Fèvre EM; Welburn SC; Odiit M; Coleman PG
BMC Infect Dis; 2008 Jun; 8():88. PubMed ID: 18590541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
